Mitologics Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Mitologics General Information


Provider of biotechnological research services intended to detect mitochondrial injury. The company's services are primarily focused on predictive toxicology, tumor targeting and mitochondrial targeting and offers compounds screening on isolated mitochondria from healthy tissues and tumor cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • Faculté de Médecine
  • 8, rue du Général Sarrail
  • 94000 Créteil
  • France
+33 06 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Mitologics’s complete valuation and funding history, request access »

Mitologics Executive Team (3)

Name Title Board Seat Contact Info
Annie Borgne-Sanchez Ph.D Co-Founder, Chief Executive, Chief Scientific Officer & President
Nelly Buron Ph.D Co-Founder & Manager, Research and Development
Mathieu Porceddu Co-Founder & Platform Manager
To view Mitologics’s complete executive team members history, request access »

Mitologics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
To view Mitologics’s complete investors history, request access »